Riskpilot← Back to searchSign inGet full accessBiotech Sweden AB
ABActiveOrg 5568861479Backa Bergögata 8Restaurant activities · NACE 5611Est. 20120 employees
Revenue 2024
SEK 104K
-59% vs 2023
EBITDA margin
22.1%
+1050% vs 2023
Equity ratio
117.8%
Financial strength
Net profit 2024
SEK 23K
+1050% vs 2023
| Revenue | SEK 104K | -59% |
| EBITDA | SEK 23K | +1050% |
| Net profit | SEK 23K | +1050% |
| Total assets | SEK 101K | +1% |
| Equity | SEK 119K | +21% |
| Employees | 0 | — |
Legal name
Biotech Sweden AB
Org number
5568861479
Legal form
Aktiebolag
NACE code
5611 · Restaurant activities
Founded
1 mars 2012
Share capital
SEK 96 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva import livsmedel och export av medicin verksamhet. Konsultverksamhet avseende företags organisation och övrig detaljhandel ej i butik. Föremålet för bolagets verksamhet är att bedriva restaurangverksamhet samt därmed förenlig verksamhet.
Address
Backa Bergögata 8
Email
info@nnajikonsult.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 440 | 40 | 4 | 254 | 104 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −40 | −1 | — | 2 | 23 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −40 | −1 | 0 | 2 | 23 |
| Net financials | — | — | — | — | — |
| Profit before tax | −40 | −1 | 0 | 2 | 23 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −40 | −1 | 0 | 2 | 23 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 88 | 97 | 97 | 100 | 101 |
| Equity | 94 | 94 | 95 | 98 | 119 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 7 | 3 | 3 | 2 | 18 |
| Total debt | 7 | 3 | 3 | 2 | 18 |
EBITDA margin
22.1%
This company
15.8%
Market median
+40% vs market
20202024
Equity ratio
117.8%
This company
38.2%
Market median
+208% vs market
20202024
Return on equity
19.3%
This company
18.4%
Market median
+5% vs market
20202024
Net profit margin
22.1%
This company
8.1%
Market median
+173% vs market
20202024
Asset turnover
1.03×
This company
1.12×
Market median
+8% vs market
20202024
Debt / equity
-0.15×
This company
0.62×
Market median
+124% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
UF Chief Executive Officer | Chief Executive Officer | 2024 |
AC Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (2) | ||
AC Authorized Recipient of Service | Authorized Recipient of Service | 2024 – 2024 |
CN Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2020 | |
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Biotech Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Uchechukwu Felix Ogbonnaya | Chief Executive Officer | 0 companies |
| Augustus Chinedu Nnaji | Chief Executive Officer | 0 companies |
| Augusta Chinonye Nnaji | Authorized Recipient of Service | 0 companies |
| Cynthia Nzubechukwu Uzomba | Chief Executive Officer | 0 companies |
| Parsa Mohaghegh Harandi | Deputy Board Member | 0 companies |
| Pouria Mohaghegh Harandi | Deputy Board Member | 0 companies |